Induction of urinary plasminogen activator by retinoic acid results in increased invasiveness of human prostate cancer cells PC‐3

No abstract is available for this paper.

• Publication year

  1995

• Venue

  The Prostate

• Publication date

  1995-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/pros.2990270506PMID 7479394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo.

  1994cited by this paper
• Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion

  1994cited by this paper
• Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts

  1994cited by this paper
• Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1.

  1993cited by this paper
• Identification of 3',5'-cyclic adenosine monophosphate-inducible nuclear factors binding to the human urokinase promoter in mouse Sertoli cells.

  1993cited by this paper
• Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblasts.

  1992cited by this paper
• Structural requirements for the growth factor activity of the amino-terminal domain of urokinase.

  1992cited by this paper
• Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B.

  1992cited by this paper
• Down-regulation of urokinase secretion from a human lymphoma cell line RC-K8 by dexamethasone without inducing plasminogen activator inhibitors.

  1992cited by this paper
• Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells.

  1992cited by this paper
• Retinoic acid priming potentiates the induction of urokinase‐type plasminogen activator by cyclic adenosine monophosphate in mouse mammary carcinoma cells

  1991cited by this paper
• Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation

  1991cited by this paper
• National Cancer Institute roundtable on prostate cancer: future research directions.

  1991cited by this paper
• Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer.

  1991cited by this paper
• An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells.

  1990cited by this paper
• Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester.

  1990cited by this paper
• Metabolism and effects of epidermal growth factor and related growth factors in mammals.

  1990cited by this paper
• Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.

  1990cited by this paper
• Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP

  1988cited by this paper
• pl Bl5: A cDNA Clone of the Rat mRNA Encoding Cyclophilin

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Plasminogen activator inhibitors.

  1987cited by this paper
• Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

  1987cited by this paper
• Proliferation of a human epidermal tumor cell line stimulated by urokinase

  1987cited by this paper
• A rapid in vitro assay for quantitating the invasive potential of tumor cells.

  1987cited by this paper
• An anticatalytic monoclonal antibody to avian plasminogen activator: its effect on behavior of RSV-transformed chick fibroblasts.

  1986cited by this paper
• Plasminogen activators, tissue degradation, and cancer.

  1985cited by this paper
• Cloning and Expression of the Gene for Pro-urokinase in Escherichia coli

  1985cited by this paper
• "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

  1984cited by this paper
• Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue.

  1984cited by this paper
• Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

  1983cited by this paper
• A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

  1983cited by this paper
• Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

  1980cited by this paper
• Proceedings: Etiology, epidemiology, and pathology of prostatic cancer.

  1973cited by this paper
• Etiology, epidemiology, and pathology of prostatic cancer

  1973cited by this paper

• The cAMP-ERK1/2 signaling pathway regulates urokinase-type plasminogen activator-induced bovine granulosa cell proliferation.

  2020cites this paper
• Inhibitors of prostasin 2-23-2010

  2016cites this paper
• REGULATED EXPRESSION OF AGGRECANASES OF ADAMTS FAMILY IN ENDOMETRIAL PHYSIOLOGY AND PATHOLOGY

  2010cites this paper
• Mechanism of action and regulation of membrane serine protease prostasin in the prostate and prostate cancer

  2007cites this paper
• Iron Stimulates Urokinase Plasminogen Activator Expression and Activates NF-kappa B in Human Prostate Cancer Cells

  2007cites this paper
• Prostasin induces protease-dependent and independent molecular changes in the human prostate carcinoma cell line PC-3.

  2007cites this paper
• A novel function of differentiation revealed by cDNA microarray profiling of p75NTR-regulated gene expression.

  2005cites this paper
• INSL3 in the benign hyperplastic and neoplastic human prostate gland.

  2005cites this paper
• DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.

  2004cites this paper
• International Congress on Hormonal Steroids and Hormones and Cancer The role of vitamin D and retinoids in controlling prostate cancer progression

  2003cites this paper
• Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.

  2003cites this paper
• Regulation of DNA Methylation in Human Breast Cancer

  2002cites this paper
• Assessment of plasminogen activator inhibitor type 2 (PAI-2) as an imaging and therapeutic agent of human cancer

  2001cites this paper
• Transcriptional regulation of gene expression in lung carcinoma cells

  2001cites this paper
• A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo

  2000cites this paper
• Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors.

  1999cites this paper
• Over‐production of parathyroid hormone–related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells In vivo

  1999cites this paper
• Growth factor involvement in progression of prostate cancer.

  1998cites this paper
• Mechanism of invasion by prostate cancer

  1998cites this paper
• Mechanisms, Hypotheses and Questions Regarding Prostate Cancer Micrometastases to Bone

  1998cites this paper
• Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase

  1997cites this paper
• Loss of response to epidermal growth factor and retinoic acid accompanies the transformation of human prostatic epithelial cells to tumorigenicity with v-Ki-ras.

  1997cites this paper
• Molecular and cellular biology of prostate cancer

  1997cites this paper
• Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428.

  1997cites this paper
• Expression of urokinase-type plasminogen activator and its receptor during ovarian follicular development.

  1997cites this paper
• Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis

  1996cites this paper